Yesterday, I wrote an article that made rounds on Twitter and substack and generated a tremendous amount of comments.
Two astute readers asked me a very reasonable question: where in the Moderna patent 9,587,003, exactly, is something that matches the Sars-Cov-2 sequence CTCCTCGGCGGGCACGTAG? I am trying to explain here.
I asked on Twitter and received a reply, and kind of deciphered the situation for myself — so here it is with screenshots and URLs. I will use screenshots so that the information is preserved even if the source is deleted or banned.
Here’s my Twitter question:
Here’s the sequence 11652 position 2733 - 2751:
So the string here is “ctacgtgc ccgccgagga g” (ignore spaces). Typing it more neatly, we get: CTACGTGCCCGCCGAGGAG in the Moderna patent sequence 11652.
Go to the “Reverse Complement Calculator”:
Now type in the genes from Sars-Cov-2 (which is CTCCTCGGCGGGCACGTAG):
So, this shows that the Sars-Cov-2 sequence CTCCTCGGCGGGCACGTAG, matches the Moderna patent sequence CTACGTGCCCGCCGAGGAG as a “reverse complement”.
This is the explanation of “reverse complement”. Remember that Sars-Cov-2 is a RNA virus and Moderna patents are DNA.
None of this tells us whether this sequence is “good”, “bad”, “pure chance”, etc. All we know is:
CTCCTCGGCGGGCACGTAG is the most crucial part of Sars-Cov-2 RNA, containing the code for the “furin cleavage site”
No natural coronaviruses contain a “furin cleavage site”
Furin cleavage site greatly enhances infectivity of Sars-Cov-2 and its ability to infect humans and other species
This code only appears in a Moderna oncology (cancer) patent 9587003, and not in any multicellular organisms or viruses known before 2020
The mutation of MSH3 gene related to this patent, is known to break DNA recombination and lead to cancers (see my previous article)
Spike protein is also known to penetrate cell nuclei and interfere with V(D)J DNA recombination and BRCA1 and p53 repair, for a reason that MAY OR MAY NOT be related to CTCCTCGGCGGGCACGTAG
BRCA mutation is responsible for breast and ovarian cancer
Someone posted a video along the same lines 2 days after my post. I like it so here it goes:
I do realize that while I answered my readers’ questions to the best of my ability, this story creates more questions that answers. Go ahead and ask them and see where all of this leads us.
This is NOT the time to pound the table with certain answers — it is time to ask probing questions.
Thanks for reading Igor’s Newsletter! Subscribe for free to receive new posts and support my work.
Thank you Igor for your dedication in digging into this stuff and getting the word out to the rest of us.
The Moderna COVID‑19 vaccine, sold under the brand name Spikevax, is a COVID-19 vaccine developed by American company Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID), and the Biomedical Advanced Research and Development Authority (BARDA). Chinese scientists put the genetic sequence of the novel coronavirus online on Jan. 11. Over the next two days, the NIH and Moderna used it to plot out a vaccine.
Afeyan remembers getting a key call about the development of the Covid-19 vaccine. “January 21st, my daughter’s birthday.... I got a call from Davos [during The World Economic Forum] from the CEO of Moderna,” he says. Bancel had been approached by a number of public health groups at the conference “urging” him to work on a vaccine. We literally decided overnight...to try and do this,” Afeyan said at MIT. Moderna delivered the first doses of its Covid-19 vaccine to the NIH for testing on Feb. 24, 2020, and “the first Moderna shot went into a volunteer’s arm in Seattle on March 16, 2020,” according to Afeyan.
So then whose idea was it to do the cancer component? NIH? NIAD? BARDA? Moderna on it's lonesome?